Literature DB >> 1681137

Isolated coronary artery bypass grafting in one hundred consecutive octogenarian patients. A multivariate analysis.

W Ko1, K H Krieger, W D Lazenby, Y T Shin, M Goldstein, R Lazzaro, O W Isom.   

Abstract

One hundred consecutive patients aged 80 or older underwent isolated coronary artery bypass grafting for New York Heart Association functional class III (24%) or IV (76%) disease in our institution from 1985 to 1989. The operations were elective in 36 patients, urgent in 52, and emergent in 12. Twenty-eight patients had significant disease of the left main coronary artery, with the remainder having an average of 2.8 diseased coronary vessels. Preoperative left ventricular ejection fraction was considered good (greater than 50%) in 62 patients, fair (30% to 50%) in 24 patients, and poor (less than 30%) in 14 patients. An average of 2.8 grafts were performed per patient, and the internal mammary artery was used in 10 patients. Univariate analysis of 36 perioperative factors followed by multivariate logistic regression analysis of the significant variables (p less than 0.05) revealed that the urgency of the operation and left ventricular ejection fraction were independent predictors of operative mortality. There were 12 in-hospital deaths, and the mortality was significantly lower in the elective cases (2.8%) than in the urgent (13.5%) and emergent cases (33.3%). Major complications occurred in 14% of the elective cases, in 21% of the urgent cases, and in 67% of the emergent cases. The operative mortality rates for good, fair, and poor left ventricular ejection fraction were 4.9%, 12.5%, and 42.9%, respectively. Long-term follow-up averaging 22 months revealed a 77% actuarial probability of survival at 24 months and 51% at 48 months, with only two cardiac-related deaths. We conclude that coronary artery bypass grafting can be performed in octogenarians with a favorable outcome when done electively in patients with normal to moderately depressed left ventricular function.

Entities:  

Mesh:

Year:  1991        PMID: 1681137

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  7 in total

1.  Cardiac surgery in nonagenarians: not only feasible, but also reasonable?

Authors:  Alexander Assmann; Jan-Philipp Minol; Arash Mehdiani; Payam Akhyari; Udo Boeken; Artur Lichtenberg
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04-28

Review 2.  [Arterial myocardial revascularization in the 9th decade of life. Personal results and review of the literature].

Authors:  A Mortasawi; I C Ennker; A Albert; U Rosendahl; F Dalladaku; T Alexander; J Ennker
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

Review 3.  Optimal treatment after acute myocardial infarction in the elderly.

Authors:  J Herlitz; M Hartford; M Dellborg; B W Karlson
Journal:  Drugs Aging       Date:  1995-03       Impact factor: 3.923

4.  Health-related quality of life after cardiac surgery--the effects of age, preoperative conditions and postoperative complications.

Authors:  Vojtěch Kurfirst; Aleš Mokráček; Martina Krupauerová; Júlia Canádyová; Alan Bulava; Ladislav Pešl; Věra Adámková
Journal:  J Cardiothorac Surg       Date:  2014-03-11       Impact factor: 1.637

5.  Coronary artery bypass grafting in the octogenarians: should we intervene, or leave them be?

Authors:  Anil Ozen; Ertekin Utku Unal; Murat Songur; Sinan Sabit Kocabeyoglu; Onur Hanedan; Metin Yilmaz; Basak Soran Turkcan; Ferit Cicekcioglu; Sadi Kaplan; Cemal Levent Birincioglu
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

6.  Coronary arteries bypass grafting surgery in elderly patients.

Authors:  Feridoun Sabzi; Hashem Kazerani; Arash Jalali; Mojgan Samadi; Fahime Ghasemi
Journal:  J Tehran Heart Cent       Date:  2013-04-28

7.  Effects of single antegrade hot shot in comparison with no hot shot administration during coronary artery bypass grafting.

Authors:  Pouya Mirmohammadsadeghi; Mohsen Mirmohammadsadeghi
Journal:  ARYA Atheroscler       Date:  2015-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.